This article describes a cross-sectional study involving 401 adults with type 1 diabetes
treated with insulin glargine in Minas Gerais, Brazil. Health-related quality of life was …

Introduction Insulin analog glargine (GLA) has been available as one of the therapeutic
options for patients with type 1 diabetes mellitus to enhance glycemic control. Studies have …

OBJETIVO: Avaliar o impacto na qualidade de vida de pacientes diabéticos que utilizam
terapia com insulina quando comparados aos diabéticos usuários da terapia padrão oral …

Objectives The study aim was to identify key factors associated with the health-related
quality of life (HRQOL) of patients with type 1 diabetes mellitus (T1DM) treated with neutral …

Glycemic control in patients with diabetes mellitus type 1 (DM1) reduces the risk of
complications but requires a rigorous health care routine. Thus, diabetes education is …

Background: A frequently cited barrier to insulin use in type 2 diabetes mellitus (DM) is
concern about the adverse effects on quality of life. Results of studies in this area have been …

Aims The results of two scales that measure quality of life of patients with diabetes mellitus
treated with conventional or analogue insulin were evaluated and compared. Methods …

OBJECTIVE—We sought to assess health-related quality of life (HRQOL) in patients with
type 2 diabetes treated with insulin glargine or rosiglitazone as add-on therapy to …

Insulin therapy becomes essential for many people with type 2 diabetes. After starting
insulin, people with diabetes that is poorly controlled with oral agents typically report …

Previous studies investigating the relationship between insulin therapy on quality of life
(QOL) in Type 2 diabetes have produced conflicting results that may reflect differences in …